Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell Marker
- 1 September 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Advances in Anatomic Pathology
- Vol. 9 (5) , 280-289
- https://doi.org/10.1097/00125480-200209000-00002
Abstract
P63 is a recently characterized p53-homolog that is consistently expressed by basal/somatic stem cells of stratified epithelia, myoepithelial cells of the breast and salivary glands, and proliferative compartment of gastric mucosa. p63 is located on the long arm of chromosome 3 (3q27) and it encodes six isoforms, three transactivating (TA) and three ΔN-isoforms. While the first three isoforms may act as tumor suppressor genes, the ΔN-isoforms may inhibit the p53/TA-p63-driven cell cycle arrest and apoptosis. Recently, the putative applications of p63 in the identification of myoepithelial cells of the breast and basal cells of the prostate acini have been evaluated; however, no critical systematic analysis of its role in surgical pathology practice have hitherto been reported. We review the putative roles of p63 in surgical pathology practice and provide guidelines for future directions on p63 translational research.Keywords
This publication has 6 references indexed in Scilit:
- p63 Is a Prostate Basal Cell Marker and Is Required for Prostate DevelopmentThe American Journal of Pathology, 2000
- Differential Expression of Myoepithelial Markers in Salivary, Sweat and Mammary GlandsInternational Journal of Surgical Pathology, 2000
- Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC SyndromeCell, 1999
- p63 is essential for regenerative proliferation in limb, craniofacial and epithelial developmentNature, 1999
- The Emerging p53 Gene FamilyJNCI Journal of the National Cancer Institute, 1999
- Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breastDiagnostic Cytopathology, 1999